Horgan AM - Search Results

1

Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.

Horgan AM, Amir E, Walter T, Knox JJ. Horgan AM, et al. J Clin Oncol. 2012 Jun 1;30(16):1934-40. doi: 10.1200/JCO.2011.40.5381. Epub 2012 Apr 23. J Clin Oncol. 2012. PMID: 22529261 Review.

2

Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.

McNamara MG, Templeton AJ, Maganti M, Walter T, Horgan AM, McKeever L, Min T, Amir E, Knox JJ. McNamara MG, et al. Among authors: horgan am. Eur J Cancer. 2014 Jun;50(9):1581-9. doi: 10.1016/j.ejca.2014.02.015. Epub 2014 Mar 11. Eur J Cancer. 2014. PMID: 24630393

3

Endoscopic or percutaneous biliary drainage for Klatskin tumors?

Walter T, Ho CS, Horgan AM, Warkentin A, Gallinger S, Greig PD, Kortan P, Knox JJ. Walter T, et al. Among authors: horgan am. J Vasc Interv Radiol. 2013 Jan;24(1):113-21. doi: 10.1016/j.jvir.2012.09.019. Epub 2012 Nov 22. J Vasc Interv Radiol. 2013. PMID: 23182938

4

Outcome of adjuvant therapy in biliary tract cancers.

McNamara MG, Walter T, Horgan AM, Amir E, Cleary S, McKeever EL, Min T, Wallace E, Hedley D, Krzyzanowska M, Moore M, Gallinger S, Greig P, Serra S, Dawson LA, Knox JJ. McNamara MG, et al. Among authors: horgan am. Am J Clin Oncol. 2015 Aug;38(4):382-7. doi: 10.1097/COC.0b013e31829e19fb. Am J Clin Oncol. 2015. PMID: 24572429

5

Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.

Loveday BPT, Knox JJ, Dawson LA, Metser U, Brade A, Horgan AM, Gallinger S, Greig PD, Moulton CA. Loveday BPT, et al. Among authors: horgan am. J Surg Oncol. 2018 Feb;117(2):213-219. doi: 10.1002/jso.24833. J Surg Oncol. 2018. PMID: 29480952

6

Adjuvant Therapy for Biliary Tract Cancers.

Horgan AM, Knox JJ. Horgan AM, et al. J Oncol Pract. 2018 Dec;14(12):701-708. doi: 10.1200/JOP.18.00558. J Oncol Pract. 2018. PMID: 30537458

7

Patterns of care and treatment outcomes in older patients with biliary tract cancer.

Horgan A, Knox J, Aneja P, Le L, McKeever E, McNamara M. Horgan A, et al. Oncotarget. 2015 Dec 29;6(42):44995-5004. doi: 10.18632/oncotarget.5707. Oncotarget. 2015. PMID: 26575326 Free PMC article.

8

An economic analysis of the INTEREST trial, a randomized trial of docetaxel versus gefitinib as second-/third-line therapy in advanced non-small-cell lung cancer.

Horgan AM, Bradbury PA, Amir E, Ng R, Douillard JY, Kim ES, Shepherd FA, Leighl NB. Horgan AM, et al. Ann Oncol. 2011 Aug;22(8):1805-11. doi: 10.1093/annonc/mdq682. Epub 2011 Jan 27. Ann Oncol. 2011. PMID: 21273345 Free article.

9

Degree of tumor shrinkage following neoadjuvant chemoradiotherapy: a potential predictor for complete pathological response in esophageal cancer?

Voncken FE, Jiang H, Kim J, Guindi M, Brierley J, Knox J, Liu G, Horgan AM, Lister J, Darling G, Metser U, Wong RK. Voncken FE, et al. Among authors: horgan am. Dis Esophagus. 2014 Aug;27(6):552-9. doi: 10.1111/j.1442-2050.2012.01445.x. Epub 2012 Nov 2. Dis Esophagus. 2014. PMID: 23121504

10

Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.

Horgan AM, Darling G, Wong R, Guindi M, Liu G, Jonker DJ, Lister J, Xu W, MacKay HM, Dinniwell R, Kim J, Pierre A, Shargall Y, Asmis TR, Agboola O, Seely AJ, Ringash J, Wells J, Marginean EC, Haider M, Knox JJ. Horgan AM, et al. Dis Esophagus. 2016 Nov;29(8):1152-1158. doi: 10.1111/dote.12444. Epub 2015 Dec 10. Dis Esophagus. 2016. PMID: 26663741 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page